WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) Sees Significant Increase in Short Interest

WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) was the target of a significant growth in short interest in September. As of September 30th, there was short interest totaling 38,536 shares, a growth of 71.6% from the September 15th total of 22,457 shares. Currently, 0.0% of the shares of the stock are sold short. Based on an average daily volume of 204,785 shares, the days-to-cover ratio is currently 0.2 days.

Wall Street Analysts Forecast Growth

Separately, Zacks Research upgraded shares of WuXi Biologics (Cayman) to a “hold” rating in a research report on Friday, August 28th. One analyst has rated the stock with a Hold rating. According to data from MarketBeat, WuXi Biologics (Cayman) has an average rating of “Hold”.

WuXi Biologics (Cayman) Stock Up 0.5%

WXXWY stock opened at $12.56 on Friday. WuXi Biologics has a 52 week low of $7.30 and a 52 week high of $14.80. The firm’s fifty day moving average is $12.90 and its 200 day moving average is $10.29.

About WuXi Biologics (Cayman)

WuXi Biologics (Cayman) Inc is a global contract research, development and manufacturing organization (CRDMO) focused on biologic medicines. The company works with pharmaceutical and biotechnology customers to support the development and production of biologic therapies, including monoclonal antibodies, recombinant proteins, vaccines and other complex biological products.

Its services span early-stage discovery and cell-line development through process development, clinical manufacturing, regulatory support and commercial-scale production.